focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Here’s another one…
The Deafening Silence: Understanding CEO Inaction During Plummeting Share Prices
Introduction:
In the tumultuous world of business, few occurrences send shockwaves as powerful as a company's share price plummeting. Amidst the chaos, one striking phenomenon often puzzles investors and stakeholders alike: the silence of CEOs. Despite the stakes and the mounting pressure, CEOs frequently opt for reticence in the face of a falling share price. This essay delves into the intricacies of this silence, exploring the underlying reasons and implications.
The Burden of Expectations:
CEOs operate under an immense burden of expectations. Shareholders, analysts, and the media scrutinize their every move, especially during times of crisis. The fear of exacerbating panic or triggering further decline may lead CEOs to adopt a cautious approach, choosing silence over potentially inflammatory statements. In a delicate balancing act, they aim to mitigate losses while maintaining confidence in the company's long-term prospects.
Legal and Regulatory Constraints:
Legal and regulatory constraints also play a pivotal role in CEO silence during share price downturns. Securities laws impose strict guidelines on public statements to prevent market manipulation and ensure transparency. CEOs must navigate these regulations carefully, avoiding statements that could be construed as misleading or deceptive. As a result, they often err on the side of caution, refraining from commentary that could inadvertently violate these laws.
Preservation of Credibility:
Preserving credibility is paramount for CEOs facing plummeting share prices. Any semblance of uncertainty or lack of control can erode investor confidence and exacerbate the crisis. By maintaining silence, CEOs seek to project an image of composure and confidence, signaling to stakeholders that they are diligently working behind the scenes to address the underlying issues. In this context, silence is not a sign of indifference but rather a strategic move to safeguard credibility amidst adversity.
Strategic Timing and Communication Channels:
Timing and choice of communication channels are critical considerations for CEOs during share price downturns. Public statements made hastily or through inappropriate channels can amplify panic and fuel speculation. CEOs often prefer to wait until they have a comprehensive understanding of the situation and a well-crafted message before addressing stakeholders. Additionally, they may opt for more controlled communication channels such as earnings calls or press releases to ensure their message is conveyed accurately and responsibly.
Blood thirsty isn’t he Timster? I popped round for afternoon tea as his Victoria sponge is an absolute delight and joy to behold. Much to my shock whilst I was enjoying a salmon cream cheese finger sandwich he was busy gnawing on one of his ferrets that’d gone lame. Between bites he told me they’ve signed a MoU with Novartis, but not to tell anyone.
I think they should move to quarterly updates and stop the Chinese whispers nonsense that’s now apparently rife. I discussed it in a lengthy email conversation with Alan. He said he burnt his toast this morning, so that explains the smell. I’m all for better comms. We don’t need conspiracies to fill the gaps.
Dx updates were in the pack. I don’t care about Dx, they bought some businesses that should bring in cash. That’s about it. Apicel is a nice to have and years away so I don’t care about that either.
Oh no! MARCH! What will we do! Be patient maybe. It’s not a very very long time, it’s not odd at all and the share price is irrelevant to their progress. Nice combo though, so morris reckons we’re due to be disappointed or there’s something spectacular on the way - then when we get a regular update, it’s disappointing. Misery inbound either way. It’s speculative nonsense. They give updates every 6 months with the interims and finals. Plus the occasional update to a select few with some Mr Kiplings - that’s the odd bit.
Are we nearly there yet? It’s a long term investment and trials take time - lots of it as it involves people making life changing decisions. Don’t expect updates every 5 minutes. No conspiracy needed. They’ll update as necessary.
It’s tough times out there. Just this month I’ve sold 24 million Amazon shares and I’m planning on selling 50 million over the next year. I’ll still be Amazon’s biggest shareholder but still, you’ve got to pay your bills.
Bein, you know it, I know it, they know it. Little point wasting energy on the never ending trail of zombie twats haunting the board. Won’t be long before they switch and the equally idiotic rockets and people doubling their holdings turn up again.
Afternoon Bein, nice to hear from you. I’m all good, hope you’re keeping well. Yeah, same old collection of twats spamming the same old FUD it seems, but all binned for me now. DTW just summed up the situation perfectly. It’s all good from a LTH perspective, the trial continues, that’s what counts. Might be time for another ‘top up’ before the next pumpathon, although they’re losing their touch.
Nothing it all. Absolutely right, I imagine that’s the direction and the type of conversations that are happening. That’s why long term holders are relaxed. A licence deal of that type, with a healthy amount of upfront cash and % of sales could potentially land at any time. It was difficult to tell, but Alan’s fumbled interview with Paul Hill vaguely described that. They’re extremely keen to do a deal rather than raise as they’ve seen how leaky the ship is and Alan has had enough of it.
It means absolutely nothing BV. This finance nonsense is regularly dredged up. They’ve cash in the bank, burn rates are down, Dx income is up. They’ve cash until the end of the year and they’ll get any cash they need via a deal or raising. End of finance FUD, back to the nonsense about Fiona.
It’s the age old ink problem Timster. First Alan’s pot ran dry just as he was about to sign transformation deals with Boris, this time the auditors are going to run out and won’t be able to sign off the accounts. We’ve had a good run. Best of luck everyone.
I noticed that codejunkie. It's not a coincidence. Bless em. 20p placing on the way it seems. Like last time that dogsh.t gravel teeth released some clickbait. Given the 1500 posts a day you'd think he'd be writing an article about HE1 and that the helium they've found is actually sulphur. Meanwhile, suppose we just wait until we're suspended because a random website says we've no cash 🤷🏻♂️
I'd suggest it all needs to be written - Qs in advance and answers in a blog post. No face to face so there's no extra info for the ego driven crowd to laud over everyone. If it's absolutely necessary then get Paul Hill involved but it definitely needs questions submitted in advance as Alan's last attempt to answer on the spot was an embarrassing garbled mess.
‘The two-weekly dosing study will aim to take patients with a more defined set of cancers than was the case in the three-weekly study and these may also have different treatment histories. This is designed to help further inform the choice of indications for the Phase 2 study. If it is possible to enrol patients earlier in their treatment journey then that is a decision for the treating oncologist.’
Suppose I'll just keep posting it. No guesswork required on this one
‘The two-weekly dosing study will aim to take patients with a more defined set of cancers than was the case in the three-weekly study and these may also have different treatment histories. This is designed to help further inform the choice of indications for the Phase 2 study. If it is possible to enrol patients earlier in their treatment journey then that is a decision for the treating oncologist.’